Although less onerous than feared, the new 15% tariff regime represents a clear deterioration in Ireland’s trading environment.  Despite that, Irish growth as measured by Modified Domestic Demand is set to be a robust 3.8% this year but slip back to 2.9% in 2026.  They are among the views in the latest quarterly economy report from the ESRI think tank, which also has a deep dive into Ireland’s pharmaceutical sector whose Irish corporation tax receipts could be in jeopardy. 

All to discuss with Dr Conor O’Toole from the ESRI.